Mr. Tzvi Palash is Chief Operating Officer of Protalix BioTherapeutics Inc. Mr. Maimon joined Protalix Ltd. in October 2006 as its Chief Financial Officer and became our Vice President and Chief Financial Officer in 2006. Prior to joining …
The Tel Aviv Stock Exchange (TASE) has approved the dual listing of Pluristem ... Pluristem operates in an innovative and experimental field, developing a placenta-derived cell therapy, PLX-PAD, for blocked arteries in the limbs and heart.
Dec 22 (Reuters) - Dipexium Pharmaceuticals Inc : * Dipexium Pharmaceuticals -following closing, dipexium will be renamed PLX Pharma Inc ... of common stock of Dipexium * Dipexium and PLX Pharma announce merger
This is the second time in three months that a patient suffering from bone marrow failure was successfully treated with its PLX cells, the Israeli company ... failed bone marrow transplants, sending its stock up 32 percent.
Supposedly, this capability is built-in to the PCI Express 3.0 specification, and PLX is able to multicast 16 lanes of traffic ... but it is the cheapest one that Newegg had in stock. A reasonable price didn’t prevent Gigabyte from stacking the …
PLX stands for placenta expanded and 18 for the word chai ... Pluristem is traded on both the Israeli stock exchange and on Nasdaq in the US. The company has a $200 million market capitalization, and gets about $4 million annually from …
Among the companies with shares expected to actively trade in Tuesday’s session are PLX Technology Inc. (PLXT), P.F. Chang’s China Bistro Inc. (PFCB) and Emerson Electric Co. (EMR). Integrated Device Technology Inc. (IDTI) said it will …
If you are buying shares, your trading house (E-Trade, Scottrade etc.) is letting those shares get sold short without having to ask you. Even if your account is not a margin acct. A way to avoid this is to put your shares up for sale at a higher …
The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $4.41 and $5.77 in the past one …